Alkermes (NASDAQ:ALKS – Get Rating) updated its FY 2023 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of $1.34-$1.57 for the period, compared to the consensus estimate of $0.75. The company issued revenue guidance of $1.55 billion-$1.68 billion, compared to the consensus revenue estimate of $1.42 billion. Analysts Set New Price […]
Alkermes (NASDAQ:ALKS – Get Rating) updated its FY 2023 earnings guidance on Friday. The company provided earnings per share guidance of $1.34-$1.57 for the period, compared to the consensus earnings per share estimate of $0.75. The company issued revenue guidance of $1.55 billion-$1.68 billion, compared to the consensus revenue estimate of $1.42 billion. Analysts Set […]
Alkermes (NASDAQ:ALKS – Get Rating) updated its FY 2023 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of $1.34-$1.57 for the period, compared to the consensus estimate of $0.75. The company issued revenue guidance of $1.55 billion-$1.68 billion, compared to the consensus revenue estimate of $1.42 billion. Wall Street Analysts Forecast […]
Auxier Asset Management reduced its stake in Alkermes plc (NASDAQ:ALKS – Get Rating) by 8.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,541 shares of the company’s stock after selling 1,200 shares during the period. Auxier Asset Management’s holdings in […]
Alkermes (NASDAQ:ALKS – Get Rating) had its target price boosted by Piper Sandler from $35.00 to $37.00 in a report issued on Wednesday, The Fly reports. Several other research firms have also issued reports on ALKS. HC Wainwright increased their price target on shares of Alkermes from $32.00 to $34.00 in a research report on […]